Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. - Wikidata - wikimedia - TriplyDB

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

http://www.wikidata.org/entity/Q37129814

about

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging Imaging tumour hypoxia with positron emission tomography Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Positron emission tomography to assess hypoxia and perfusion in lung cancer Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment Predictive Response Value of Pre- and Postchemoradiotherapy Variables in Rectal Cancer: An Analysis of Histological Data Molecular mechanisms of hypoxia in cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.Molecular imaging in cancer treatment.Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Microwave gallium-68 radiochemistry for kinetically stable bis(thiosemicarbazone) complexes: structural investigations and cellular uptake under hypoxia.Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx Development of copper based drugs, radiopharmaceuticals and medical materials.The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin.Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide Copper-64 Radiopharmaceuticals for Oncologic Imaging Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.Incorporating prognostic imaging biomarkers into clinical practice.Molecular imaging of hypoxia with radiolabelled agents Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.Positron Emission Tomography Imaging of Hypoxia.Techniques of assessing hypoxia at the bench and bedside.PET imaging of cardiac hypoxia: opportunities and challenges.Innovation in cancer imaging.Advances in oncologic imaging: update on 5 common cancers.Imaging hypoxia to improve radiotherapy outcome.Predicting tumour response.

P2860

Q26784016-E93DFB53-268F-435B-B526-AEEA9E3B9C3D Q26851422-A20D3F4B-6B7D-4366-8A2A-ED92D7137622 Q27007505-84CAC89A-910C-42FA-8920-A20EE4083D55 Q27025579-3BBF0145-D51B-42FB-8E4F-A937A62FF114 Q27026940-5D6D2C01-3D03-4114-B3C4-A96B4ECE5D0D Q30659261-B01248DB-EE72-41EF-AEC0-E5BC150F90FB Q30858109-4416820A-269F-459C-BEE6-95562C68DA59 Q31046735-8A4EA31E-E8F0-4908-8E2D-FFF3770E7583 Q33705108-78FC46F2-BB2F-43C7-8753-49A839C9558B Q33818999-952F04BF-697D-4315-A61A-E16F5F498BD8 Q34235986-C6001A7E-7463-47D6-996B-75504EA3EE4C Q34315607-5C3E4CAD-9795-4038-BB5F-DD70057A1B20 Q34496670-F25622D4-56E4-4FDA-BFF3-BDF1E677E025 Q34696310-B791E79D-DBDA-4589-8F92-C7E5518038A4 Q35116540-7D27E001-BA61-4654-88D8-3B5BA91D3844 Q35165000-AB91E383-4395-476B-B20F-2B9938509AFC Q35504360-EC37220A-535A-4307-861D-69510977A72A Q35545519-4656E65A-71AD-4B5C-BAC6-E69792E2A25A Q35545523-AB0DDB21-9FAF-47DA-9DD5-EAC977312355 Q35565683-FF9ADFBE-D5B2-442C-B445-88E1C9878BF8 Q35846041-9B599442-495B-4B4F-8B49-AC38D185B9DF Q36020018-FADBAE33-30B7-4900-B6B7-8DE5A53C4EED Q36335266-95837450-648A-4DF6-BA0B-AE791E7AD7F4 Q36387970-4961DDBF-2351-45EE-9493-500B10641BF6 Q36394415-A2138A39-96D5-4E0F-AB4D-46070137E2B1 Q36779858-AC66C270-F8DE-4FE6-9D6C-18FB2B488093 Q36998241-0A1316C1-3688-4268-955A-B8DB65376CDB Q37126530-86C0F05D-690A-4DB6-BF8A-DBFFF6DBC3BA Q37140996-2F3A7D0B-95C4-4498-8E00-C707ECAC9AF1 Q37193816-7A7C75EB-2F67-4198-A46E-6FCF383C42FA Q37378239-0645803A-F59B-4060-8833-CD7BAE149CED Q37414432-AE776AF0-31B9-4937-A329-6BFD9DDCE1B5 Q37506093-A81B9161-3627-461B-994F-1B52721E9844 Q37666742-3056CB44-F034-4A9E-9A87-86D83C7D552D Q37843729-98890F03-4F05-4F4F-B473-16CD52A182BE Q37904019-88A7D023-D0A9-4E21-A7DA-D0AA461C1139 Q38005915-5C86DDF2-23E7-4A14-838F-9FACCEC89359 Q38052458-91344F24-7417-4879-86C7-245CDA1F37C3 Q38059626-49675FB1-3C69-48BF-B941-3248C2FFC7E1 Q38141699-E2C6341F-49E6-48C0-ADF2-994D4660C26D

P2860

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

http://www.wikidata.org/entity/Q37129814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@en

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@nl

type

label

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@en

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@nl

prefLabel

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@en

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@nl

P1433

Q37129814-7AD52015-47DC-4A4C-B5DB-13FB38BD45FD

P1476

Q37129814-26EDC306-37A3-4348-ACCC-F12198207DE9

P2093

Q37129814-1FFB9383-374E-4E35-BF6E-DC25456225EC

Q37129814-44537AD5-2A7B-4CF5-9753-81655FD7D441

Q37129814-51EA76BA-216C-4FEE-AB2E-89CDDAF24D3E

Q37129814-5B3D7887-43B8-4698-B3BB-958C6935F46E

Q37129814-6C51C37F-49F2-45E6-BADE-0078741CC264

Q37129814-6D9EDD45-43D1-4A6A-9737-9BEA40AF1C88

Q37129814-6DE1206C-3D9C-496E-A706-45E2454648E7

Q37129814-9F432B06-5825-4852-B953-1954D8327A2F

Q37129814-AB5226FC-11D2-4B83-923C-4F6C8503099C

Q37129814-AC2EF580-B583-47FF-8BA0-CDBEB607FCE2

P2860

Q37129814-16D5BEFA-759E-4FDB-A9CD-F6536FDEB134

Q37129814-18A22ECB-DCC7-4385-8D24-06F35CC25221

Q37129814-22429898-E888-4D5C-9879-6CADDAA8D421

Q37129814-2419F7BC-47A3-40A0-8C44-16DF424A9579

Q37129814-30276016-9EBF-4144-8732-E32E4F358ED2

Q37129814-30C49E34-B76F-4FA4-B1ED-22D09ABFAAD0

Q37129814-4EC420E1-0C83-4DFD-86EA-1943BF67E868

Q37129814-72C3AF2A-EA19-43A8-9E6F-A5D2AB6AD384

Q37129814-79F6DD10-A925-408D-A471-06DBFB385336

Q37129814-84219155-4EB9-4F84-9232-83FBD111D58A

P2888

Q37129814-D603839D-081C-4D32-B9EE-17D3FA4FECF6

P304

Q37129814-3489EDAB-3E42-4994-A323-911981732A73

P31

Q37129814-BD70DF75-AA7D-4F75-B2E8-9A0144FDC0D1

P356

Q37129814-276C0314-3D63-451D-8E7B-637F9008A910

P433

Q37129814-68EE133D-C483-49AA-9907-C944E2463A03

P478

Q37129814-BB272286-B93C-4841-BC7D-C672C35F1B4E

P577

Q37129814-CE77780A-6E69-4B7F-824C-9455DD955A33

P698

Q37129814-473536CE-79FD-40A5-9310-23A3C5483886

P921

Q37129814-CB5E07AD-90EC-4A50-8A10-3AC1C961400D

Q37129814-E6C2E529-9211-4C2E-8E0D-1C4BBDEB9C04

Q37129814-F8B1AE0B-C33E-4028-A89E-F573000B2D1F

P932

Q37129814-1C0E0E0D-CEC8-45A3-89D6-468BCA9DD53C

P356

S10350-008-9420-3

P1433

Diseases of the Colon & Rectum

P1476

Tumor hypoxia detected by posi ...... ctal carcinoma: a pilot study.

@en

P2093

Barry A Siegel

http://www.w3.org/2001/XMLSchema#string

David W Dietz

http://www.w3.org/2001/XMLSchema#string

Farrokh Dehdashti

http://www.w3.org/2001/XMLSchema#string

Jason S Lewis

http://www.w3.org/2001/XMLSchema#string

Joel Picus

http://www.w3.org/2001/XMLSchema#string

Jon Ritter

http://www.w3.org/2001/XMLSchema#string

Michael J Welch

http://www.w3.org/2001/XMLSchema#string

Perry W Grigsby

http://www.w3.org/2001/XMLSchema#string

Robert J Myerson

http://www.w3.org/2001/XMLSchema#string

Robert S Malyapa

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2007

Induction chemoradiation for rectal cancer.

RETRACTED: PET imaging of tumour hypoxia.

The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure.

Pre-operative combined modality therapy in the management of locally advanced rectal cancer.

Exogenous and endogenous markers of tumour oxygenation status: definitive markers of tumour hypoxia?

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

Hypoxia in head and neck cancer.

Alternative clinical end points in rectal cancer--are we getting closer?

A multimodality approach to localized rectal cancer.

P2888

s10350-008-9420-3

P304

1641-1648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10350-008-9420-3

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18682881

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4962601

http://www.w3.org/2001/XMLSchema#string